A chemical mutagenesis screen to identify modifier genes that interact with growth hormone and TGF-β signaling pathways

Bone

Volumn 42, Issue 2, 2008, Pages 388-395

  Mohan, Subburaman ^a,b   Baylink, David J ^b   Srivastava, Apurva K ^a,b  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone size; Ghrhr; Modifier genetic screen; N ethyl N nitrosourea; Smad2

Indexed keywords

ETHYLNITROSOUREA; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR RECEPTOR; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; KNOCKOUT MOUSE; MALE; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN DNA INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; DRUG EVALUATION, PRECLINICAL; FEMALE; GROWTH HORMONE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTAGENESIS; PHENOTYPE; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 37849030722     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2007.10.014     Document Type: Article

References (35)

1. Nolan P.M., Peters J., Vizor L., Striven M., Washbourne R., Hough T., et al. Implementation of a large-scale ENU mutagenesis program: towards increasing the mouse mutant resource. Mamm Genome (2000) 500-506
2. O'Brien T.P., and Frankel W.N. Moving forward with chemical mutagenesis in the mouse. J Physiol (2004) 13-21
3. Justice M.J. Capitalizing on large-scale mouse mutagenesis screens. Nat Rev Genet (2000) 109-115
4. Thaung C., West K., Clark B.J., McKie L., Morgan J.E., Arnold K., et al. Novel ENU-induced eye mutations in the mouse: models for human eye disease. Human Molecular Genetics (2002) 755-767 England
5. Speca D.J., Rabbee N., Chihara D., Speed T.P., and Peterson A.S. A genetic screen for behavioral mutations that perturb dopaminergic homeostasis in mice. Genes Brain Behav (2006) 19-28
6. Tchekneva E.E., Rinchik E.M., Polosukhina D., Davis L.S., Kadkina V., Mohamed Y., et al. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy. J Am Soc Nephrol (2007) 103-112
7. Ahituv N., and Avraham K.B. Mouse models for human deafness: current tools for new fashions. Trends Mol Med 8 9 (2002) 447-451
8. Srivastava A.K., Kapur S., Mohan S., Yu H., Wergedal J., and Baylink D.J. Identification of novel genetic loci for bone size and mechanosensitivity in an ENU mutant exhibiting decreased bone size. J Bone Miner Res 20 6 (2005) 1041-1050
9. Srivastava A.K., Mohan S., Wergedal J.E., and Baylink D.J. A genomewide screening of N-ethyl-N-nitrosourea-mutagenized mice for musculoskeletal phenotypes. Bone 33 2 (2003) 179-191
10. Hoyne G.F., and Goodnow C.C. The use of genomewide ENU mutagenesis screens to unravel complex mammalian traits: identifying genes that regulate organ-specific and systematic autoimmunity. Immunol Rev 210 (2006) 27-39
11. Go M.J., and Artavanis-Tsakonas S. A genetic screen for novel components of the notch signaling pathway during Drosophila bristle development. Genetics 150 1 (1998) 211-220
12. Carrera P., Abrell S., Kerber B., Walldorf U., Preiss A., Hoch M., et al. A modifier screen in the eye reveals control genes for Kruppel activity in the Drosophila embryo. Proc Natl Acad Sci U S A 95 18 (1998) 10779-10784
13. Abrell S., Carrera P., and Jackle H. A modifier screen of ectopic Kruppel activity identifies autosomal Drosophila chromosomal sites and genes required for normal eye developmant. Chromosoma 109 5 (2000) 334-342
14. Tchekneva E.E., Rinchik E.M., Polosukhina D., Davis L.S., Kadkina V., Mohamed Y., et al. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy. J Am Soc Nephrol 18 1 (2007) 103-112
15. Rubio-Aliaga I., Soewarto D., Wagner S., Klaften M., Fuchs H., Kalaydjiev S., et al. A genetic screen for modifiers of the delta1-dependent notch signaling function in the mouse. Genetics 175 3 (2007) 1451-1463
16. Howell G.R., Shindo M., Murray S., Gridley T., Wilson L.A., and Schimenti J.C. Mutation of a ubiquitously expressed mouse transmembrane protein (Tapt1) causes specific skeletal homeotic transformations. Genetics 175 2 (2007) 699-707
17. Inoue M., Sakuraba Y., Motegi H., Kubota N., Toki H., Matsui J., et al. A series of maturity onset diabetes of the young, type 2 (MODY2) mouse models moderated by a large-scale ENU mutagenesis program. Hum Mol Genet 13 11 (2004) 1147-1157
18. Satterthwaite A.B., Willis F., Kanchanastit P., Fruman D., Cantley L.C., Helgason C.D., et al. A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase. Proc Natl Acad Sci U S A 97 12 (2000) 6687-6692
19. Godinho S.I., and Nolan P.M. The role of mutagenesis in defining genes in behavior. Eur J Hum Genet 14 6 (2006) 651-659
20. Mohan S., Richman C., Guo R., Amaar Y., Donahue L.R., Wergedal J., et al. Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology 144 3 (2003) 929-936
21. Attisano L., and Wrana J.L. Signal transduction by the TGF-beta superfamily. Science 296 5573 (2002) 1646-1647
22. Donahue L.R., and Beamer W.G. Growth hormone deficiency in little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J Endocrinol 136 1 (1993) 91-104
23. Godfrey P., Rahal J.O., Beamer W.G., Copeland N.G., Jenkins N.A., and Mayo K.E. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 4 3 (1993) 227-232
24. Liu Y., Festing M., Thompson J.C., Hester M., Rankin S., El-Hodiri H.M., et al. Smad2 and Smad3 coordinately regulate craniofacial and endodermal development. Dev Biol 270 2 (2004) 411-426
25. Ferguson C.A., Tucker A.S., Heikinheimo K., Nomura M., Oh P., Li E., et al. The role of effectors of the activin signalling pathway, activin receptors IIA and IIB, and SMAD2, in patterning of tooth development. Development 128 22 (2001) 4605-4613
26. Zhou Y., Scolavino S., Funderburk S.F., Ficociello L.F., Zhang X., and Klibanski A. Receptor internalization-independent activation of Smad2 in activin signaling. Mol Endocrinol 18 7 (2004) 1818-1826
27. Weinstein M., Yang X., Li C., Xu X., Gotay J., and Deng C.X. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proc Natl Acad Sci U S A 95 16 (1998) 9378-9383
28. Weber J.S., Salinger A., and Justice M.J. Optimal N-ethyl-N-nitrosourea (ENU) doses for inbred mouse strains. Genesis 26 4 (2000) 230-233
29. Kasukawa Y., Baylink D.J., Guo R., and Mohan S. Evidence that sensitivity to growth hormone (GH) is growth period and tissue type dependent: studies in GH-deficient lit/lit mice. Endocrinology 144 9 (2003) 3950-3957
30. Mohan S., and Baylink D.J. Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences. J Endocrinol (2005) 415-420
31. Walenkamp M.J., Karperien M., Pereira A.M., Hilhorst-Hofstee Y., van Doorn J., Chen J.W., et al. Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. J Clin Endocrinol Metab (2005) 2855-2864
32. Chubb C. Biol Reprod 37 3 (1987) 564-569
33. Maheshwari H.G., Bouillon R., Nijs J., Oganov V.S., Bakulin A.V., and Baumann G. The impact of congenital, severe, untreated growth hormone (GH) deficiency on bone size and density in young adults: insights from genetic GH-releasing hormone receptor deficiency. J Clin Endocrinol Metab (2003) 2614-2618
34. Zhang X.Z., Kalu D.N., Erbas B., Hopper J.L., and Seeman E. The effects of gonadectomy on bone size, mass, and volumetric density in growing rats are gender-, site-, and growth hormone-specific. J Bone Miner Res (1999) 802-809
35. Lindberg M.K., Vandenput L., Moverare Skrtic S., Vanderschueren D., Boonen S., Bouillon R., et al. Minerva Endocrinol 30 1 (2005) 15-25